On Friday, Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) was 9.16% up from the session before settling in for the closing price of $20.31. A 52-week range for ARCT has been $8.04 – $25.88.
It was noted that within the last five years, the titan of the Healthcare sector saw sales slided by -6.84%. When this article was written, the company’s average yearly earnings per share was at 14.81%. With a float of $24.86 million, this company’s outstanding shares have now reached $27.15 million.
Arcturus Therapeutics Holdings Inc (ARCT) Insider and Institutional Ownership
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Arcturus Therapeutics Holdings Inc stocks. The insider ownership of Arcturus Therapeutics Holdings Inc is 8.44%, while institutional ownership is 95.20%. The most recent insider transaction that took place on Oct 15 ’24, was worth 249,121. In this transaction Chief Scientific Officer & COO of this company sold 12,000 shares at a rate of $20.76, taking the stock ownership to the 435,334 shares. Before that another transaction happened on Oct 15 ’24, when Company’s Officer proposed sale 12,000 for $20.76, making the entire transaction worth $249,121.
Arcturus Therapeutics Holdings Inc (ARCT) Latest Financial update
Going through the last 3-months fiscal report unveiled on the 9/30/2024, it has been observed that the corporation posted -0.26 earnings per share (EPS) during the time that was better than consensus figure (set at -1.02) by 0.76. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.94 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 14.81% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 56.02% during the next five years compared to -6.84% drop over the previous five years of trading.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Trading Performance Indicators
You can see what Arcturus Therapeutics Holdings Inc (ARCT) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 5.90. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 5.48.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.22, a number that is poised to hit -0.83 in the next quarter and is forecasted to reach -2.43 in one year’s time.
Technical Analysis of Arcturus Therapeutics Holdings Inc (ARCT)
The latest stats from [Arcturus Therapeutics Holdings Inc, ARCT] show that its last 5-days average volume of 0.64 million was superior to 0.49 million than last year’s volume. As of the previous 9 days, the stock’s Stochastic %D was 80.29%.
During the past 100 days, Arcturus Therapeutics Holdings Inc’s (ARCT) raw stochastic average was set at 98.05%, which indicates a significant increase from 96.08% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 1.17 in the past 14 days, which was higher than the 1.03 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.55, while its 200-day Moving Average is $14.72. Now, the first resistance to watch is $22.88. This is followed by the second major resistance level at $23.58. The third major resistance level sits at $24.77. If the price goes on to break the first support level at $20.99, it is likely to go to the next support level at $19.80. The third support level lies at $19.10 if the price breaches the second support level.
Arcturus Therapeutics Holdings Inc (NASDAQ: ARCT) Key Stats
There are 27,155K outstanding shares of the company, which has a market capitalization of 602.02 million. As of now, sales total 152,310 K while income totals -80,940 K. Its latest quarter income was 28,300 K while its last quarter net income were -9,180 K.
